Narrative Policy Analysis
Medical Marijuana Policy in Indonesia
DOI:
https://doi.org/10.21787/mp.5.1.2021.13-24Keywords:
medical marijuana, public policy, narrative policy analysis, IndonesiaAbstract
Policy concern on medical marijuana utilization as diseases treatment or pain reliever still debated in many countries, also in Indonesia. This study aim to find government’s narrative relate to medical marijuana policy in Indonesia, analyze the resistance of its implementation, and formulate alternative strategies. Narrative Policy Analysis (NPA) applied to analyze the narrative disparity on government’s medical marijuana policies and to specify narrative form, as well as level of analysis, setting, character, plot, and moral of the policy narrative. Data gathered from trusted online documents such as public data, media coverage, or speech transcripts relevant to research issues from January 2019 to December 2020. Study find that 1) Government still forbid medical marijuana use in order to protect people from risk and unexpected problems; 2) Narrative policy develop by the government hampered by different belief system about marijuana and the lack of empirical study about medical marijuana in Indonesia; 3) Some of strategy recommendations to enhance government policy narrative related to medical marijuana were organize an open discussion with the contra community, conduct empirical study with academics to strengthen arguments and policy narrative, and socialize medical marijuana policy to various stakeholders.
References
Aldino, Hanri. (2018). Persepsi mahasiswa terhadap gagasan legalisasi ganja di indonesia. Jurnal Hukum Samudra Keadilan, 13(35), 234–249. https://doi.org/https://doi.org/10.33059/jhsk.v13i2.906
Apriansyah, Tofa, Purwadianto, Agus, & Hanita, Margaretha. (2020). Narrative Policy Analysis : Trade-Off Pelayanan Dan Pengawasan Pasca Paket Kebijakan Ekonomi Xv. Jurnal Perspektif Bea Dan Cukai, 4(1), 1–19.
Bahar, Yul Harry. (2016). Kebijakan pengembangan tanaman obat. 33(66), 1–20.
Berlinger, Joshua. (2016). Germany to legalize medicinal marijuana by 2017. Retrieved March 25, 2021, from CNN.com website: https://edition.cnn.com/2016/05/04/europe/germany-medicinal-marijuana/
Blimkin, L., Libzon, S., Bar-Lev Schleider, L., Saban, N., Levit, L., Zerem, A., Linder, I., Pelleg, K., & Lerman-Sagie, T. (2017). Medical cannabis in children with complex motor disorders. European Journal of Paediatric Neurology, 21, e219. https://doi.org/10.1016/j.ejpn.2017.04.1132
BNN. (2019). Indonesia drugs report 2019. Jakarta.
BNN. (2020). Indonesia Drug Report 2020.
Dwiguna, Adrianus R., & Munandar, Adis I. (2020). ANALISIS NARATIF KEBIJAKAN PANGAN NASIONAL MELALUI PROGRAM FOOD ESTATE NARRATIVE ANALYSIS OF NATIONAL FOOD POLICY THROUGH THE FOOD ESTATE PROGRAM. Publica : Jurnal Administrasi Pembangunan Dan Kebijakan Publik, 11(2), 273–284.
ECDD WHO. (2017). Cannabidiol (CBD). In ECDD Thirty-ninth Meeting. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/32310508
Filbey, Francesca M., Aslan, Sina, Calhoun, Vince D., Spence, Jeffrey S., Damaraju, Eswar, Caprihan, Arvind, & Segall, Judith. (2014). Long-term effects of marijuana use on the brain. Proceedings of the National Academy of Sciences of the United States of America, 111(47), 16913–16918. https://doi.org/10.1073/pnas.1415297111
Gil. (2020). Tarik Ulur Regulasi Ganja Medis di Indonesia. Retrieved December 24, 2020, from https://www.cnnindonesia.com/nasional/20200831090732-20-540996/tarik-ulur-regulasi-ganja-medis-di-indonesia
Government of Canada. (2020). What you need to know about cannabis - Canada.ca. Retrieved March 25, 2021, from Canada.ca website: https://www.canada.ca/en/services/health/campaigns/cannabis/canadians.html#a11
Hand, Andrew, Blake, Alexia, Kerrigan, Paul, Samuel, Phineas, & Friedberg, Jeremy. (2017). History of medical cannabis. Cannabis: Medical Aspects, 9(4), 17–26.
Humas BNN. (2020a). BNN Tegas Menolak Legalisasi Ganja. Retrieved January 15, 2021, from https://bnn.go.id/bnn-tegas-menolak-legalisasi-ganja/
Humas BNN. (2020b). Hasil Voting Pada Reconvened 63rd Session Commision On Narcotics Drugs Terkait Cannabis dan Cannabis Resin. Retrieved January 5, 2021, from https://bnn.go.id/hasil-voting-pada-reconvened-63rd-session-commision/
IJRS. (2020a). [Rilis Pers] Koalisi Masyarakat Sipil Meminta Dasar Pemerintah Menolak Rekomendasi WHO terkait Ganja Medis untuk Dibuka ke Publik. Retrieved January 15, 2021, from http://ijrs.or.id/rilis-pers-koalisi-masyarakat-sipil-meminta-dasar-pemerintah-menolak-rekomendasi-who-terkait-ganja-medis-untuk-dibuka-ke-publik/
IJRS. (2020b). PBB Ubah Sistem Penggolongan Narkotika yang Memperkuat Posisi Ganja Medis. Retrieved January 5, 2021, from http://ijrs.or.id/pbb-ubah-sistem-penggolongan-narkotika-yang-memperkuat-posisi-ganja-medis/
Koagouw, Miechell Octovy. (2020). Semua yang Usul Legalisasi Ganja Patut Dicurigai - Peristiwa |. Retrieved December 9, 2020, from rri.co.id website: https://rri.co.id/nasional/peristiwa/890900/semua-yang-usul-legalisasi-ganja-patut-dicurigai
Lee, Gemayel, Grovey, Brittany, Furnish, Tim, & Wallace, Mark. (2018). Medical Cannabis for Neuropathic Pain. Current Pain and Headache Reports, 22(1). Retrieved from http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L620498523%0Ahttp://dx.doi.org/10.1007/s11916-018-0658-8
Lokollo, Leonie, Salamor, Yonna Beatrix, & Ubwarin, Erwin. (2020). Kebijakan Formulasi Undang-undang Narkotika Dalam Legalisasi Penggunaan Ganja Sebagai Bahan Pengobatan di Indonesia. Jurnal Belo, 5(2), 1–20. https://doi.org/10.30598/belovol5issue2page1-20
Maa, Edward, & Figi, Paige. (2014). The case for medical marijuana in epilepsy. Epilepsia, 55(6), 783–786. https://doi.org/10.1111/epi.12610
Mahdizadeh, Shahla, Ghadiri, Maryam Khaleghi, & Gorji, Ali. (2015). Avicenna’s Canon of Medicine: a review of analgesics and anti-inflammatory substances. AJP, 5(3), 182–202.
Martinez, Magdalena. (2019). An Examination of Higher Education Policy Problems Using Narrative Policy Analysis. American Behavioral Scientist, 63(3), 369–386. https://doi.org/10.1177/0002764218820569
O’Leary, Renée, Borland, Ron, Stockwell, Tim, & MacDonald, Marjorie. (2017). Claims in vapour device (e-cigarette) regulation: A Narrative Policy Framework analysis. International Journal of Drug Policy, 44, 31–40. https://doi.org/10.1016/j.drugpo.2017.03.004
Parama, I. Dewa Made Satya, Ranteallo, Ikma Citra, & Kebayantini, Ni Luh Nyoman. (2015). Peran lingkar ganja nusantara dalam legalisasi ganja. Jurnal Sosial, 2, 1–12.
Pitri Susanti, Ni. (2012). Identifikasi Kandungan Cannabinoid Dalam Ekstrak Batang Ganja Dengan Metode Al-Tlc Dan Hptlc Spectrophotodensitometry. Indonesian Journal of Legal and Forensic Sciences, 2(1), 282193. Retrieved from https://ojs.unud.ac.id/index.php/ijlfs/article/view/3249
Putra, M. Taufan Perdana. (2014). KEBIJAKAN PENDAYAGUNAAN HEMP (Ganja Industri) UNTUK KEPENTINGAN INDUSTRI DI INDONESIA. Jurnal Hukum, 8.
Republik Indonesia. (2009). Undang-Undang No. 35 Tahun 2009 tentang Narkotika.
Rosana, Fransiscus Christy. (2020). Politikus PKS Jelaskan Rencana Legalisasi hingga Ekspor Ganja - Bisnis Tempo.co. Retrieved December 24, 2020, from https://bisnis.tempo.co/read/1302001/politikus-pks-jelaskan-rencana-legalisasi-hingga-ekspor-ganja/full&view=ok
Shanahan, Elizabeth A., Jones, Michael D., & McBeth, Mark K. (2017). How to conduct a Narrative Policy Framework study. Social Science Journal, 55(3), 332–345. https://doi.org/10.1016/j.soscij.2017.12.002
Siahaan, Selma, & Aryastami, Ketut. (2018). Studi Kebijakan Pengembangan Tanaman Obat di Indonesia. 157–166.
The Open University. (2017). Research methods: Narrative policy analysis. Retrieved December 9, 2020, from https://www.open.edu/openlearncreate/mod/oucontent/view.php?id=13636§ion=5.1
Wang, Julie B., Ramo, Danielle E., Lisha, Nadra E., & Cataldo, Janine K. (2016). Medical marijuana legalization and cigarette and marijuana co-use in adolescents and adults. Drug and Alcohol Dependence, 166, 32–38. https://doi.org/10.1016/j.drugalcdep.2016.06.016
Whitcomb, B., Lutman, C., Pearl, M., Medlin, E., Prendergast, E., Robison, K., & Burke, W. (2019). Use of cannabinoids in cancer patients: A Society of Gynecologic Oncology (SGO) clinical practice statement. Gynecologic Oncology, 157(2), 307–311. https://doi.org/10.1016/j.ygyno.2019.12.013
Whiting, Penny F., Wolff, Robert F., Deshpande, Sohan, Di Nisio, Marcello, Duffy, Steven, Hernandez, Adrian V., Keurentjes, J. Christiaan, Lang, Shona, Misso, Kate, Ryder, Steve, Schmidlkofer, Simone, Westwood, Marie, & Kleijnen, Jos. (2015). Cannabinoids for medical use: A systematic review and meta-analysis. JAMA - Journal of the American Medical Association, 313(24), 2456–2473. https://doi.org/10.1001/jama.2015.6358
Yuan, Melissa, Kanellopoulos, Theodora, & Kotbi, Nabil. (2019). Cannabis use and psychiatric illness in the context of medical marijuana legalization: A clinical perspective. General Hospital Psychiatry, 61(July), 82–83. https://doi.org/10.1016/j.genhosppsych.2019.08.003
Zuardi, Antonio Waldo. (2005). History of cannabis as a medicine: a review. Brazilian Journal of Psychiatry.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Creative Commons-Attribution-Noncommercial-Share Alike License 4.0 International applies to all works published by Matra Pembaruan: Jurnal Inovasi Kebijakan. Authors will retain copyright of the work.
